Research Fellow

Maëva Chauvin joined the Pépin Laboratory in 2020 after completing her PhD at the Institut de Recherche en Cancérologie (Cancer Research Institute) in Montpellier, France, where she studied the role of anti-Müllerian hormone and its receptors in gynecological cancers and developed therapeutic antibodies. She is currently investigating how the AMH/AMHR2 pathway may regulate the tumor microenvironment in ovarian cancer.

Her research focuses on understanding the role of Cancer-Associated Mesothelial Cells (CAMCs) in the ovarian cancer tumor microenvironment. She explores how the cancer secretome and the TGFβ family, including AMH/AMHR2 signaling, drive mesothelial cell reprogramming and contribute to immune evasion and treatment resistance. By combining in vitro and in vivo models, spatial transcriptomics, and advanced immunophenotyping, she aims to characterize the molecular mechanisms governing CAMC differentiation and function.